"Two novel products for the treatment of non-small-cell lung cancer (NSCLC) have been recommended for approval in Europe: osimertinib (Tagrisso, AstraZeneca) and necitumumab (Portrazza, Eli Lilly).
IMPORTANT: HOW TO USE THIS INFORMATION: This is a summary and does NOT have all possible information about this product. This information does not assure that this product is safe, effective, or appropriate for you. This information is not individual medical advice and does not substitute for the advice of your health care professional. Always ask your health care professional for complete information about this product and your specific health needs.
TOPOTECAN - INJECTION
COMMON BRAND NAME(S): Hycamtin
WARNING: Topotecan may cause very serious (possibly fatal) blood disorders (decreased bone marrow function leading to low number of blood cells such as white cells, red cells, and platelets). This effect can decrease your body's ability to fight an infection, cause your body to bruise or bleed easier, or cause anemia. Tell your doctor if you develop any of the following conditions: signs of an infection (such as fever, persistent sore throat), easy bruising/bleeding, unusual tiredness, fast/pounding heartbeat.
You will be closely monitored (e.g., with frequent blood tests) by your doctor while using this medication. Keep all medical and laboratory appointments.
USES: This medication is used to treat cancer of the ovaries or lungs when other treatments have not been successful. It is also used with another medication (cisplatin) to treat cancer of the cervix.
OTHER USES: This section contains uses of this drug that are not listed in the approved professional labeling for the drug but that may be prescribed by your health care professional. Use this drug for a condition that is listed in this section only if it has been so prescribed by your health care professional.
This medication may also be used to treat other types of cancer (such as bone cancer).
HOW TO USE: This medication is given by injection into a vein by a health care professional. The dosage is based on your medical condition, body size, laboratory tests, and response to treatment.
If this medication comes into contact with your skin, wash the skin immediately and completely with soap and water. If this medication gets into your eyes, mouth, or nose, flush completely with plenty of water. Consult your doctor for more information.
Additional Hycamtin Information
Hycamtin - User Reviews
Hycamtin User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Get the latest treatment options.